12,372 trials
Schizoaffective Disorder
Primary: Double-blind: Percentage of Participants Who Experienced Relapse — 15.2; 33.5; 11.5; 32.9 percentage of participants — p=<0.001
Chronic Obstructive Pulmonary Disease
Primary: Change From Baseline in Mean Trough Forced Expiratory Volume in 1 Second (FEV1) (NVA237 Versus Tiotropium) — 0.095; 0.102 liters
Type 2 Diabetes Mellitus
Primary: Number of Participants With Adverse Events — 6; 7; 136; 84 participants
Adenocarcinoma of the Lung · Adenosquamous Cell Lung Cancer · Bronchoalveolar Cell Lung Cancer
Primary: Overall Survival — 0.52; 0.57 percentage of 5 years survival rate — p=0.14
Bacterial Meningitis
Primary: Percentages of Subjects With Human Serum Bactericidal Assay (hSBA) Seroresponse Against N.Meningitidis Serogroup A. — 75; 76; 66; 72 Percentages of subjects
Diabetes
Primary: Number of Subjects That Were Diagnosed for Peri-operative Complications — 58; 70 participants
Diseases, Metabolic · Insulin Sensitivity
Primary: Flow Mediated Dilation — 10.3; 8.9; 9.2; 9.1 percentage of brachial artery diameter
Chronic Hepatitis C Virus
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Discontinuation of Therapy (SVR12) — 94.0; 93.1; 96.3 percentage of participants — p=<0.001
Multiple Myeloma
Primary: Number of Participants With Adverse Events (AE) During the Treatment Phase — 327; 268; 256; 177 participants
Non-Small Cell Lung Cancer
Primary: Progression-Free Survival (PFS) Time — 4.27; 2.60 months
Non-Small Cell Lung Cancer
Primary: Overall Survival — 10.5; 9.1 months
Short Bowel Syndrome
Primary: Summary of Treatment-emergent Adverse Events — 4; 5 participants
Diabetes Mellitus, Type 2
Primary: Change in Area Under the Concentration-time Curve (AUC1-4h) for Postprandial Plasma Glucose From Baseline After 28 Days of Treatment — -18.07; -103.56; -122.94 mg*h/dL…
Short Bowel Syndrome
Primary: Percent Change in PN/IV Volume by Visit — -5.35; -6.44; -40.65; -12.88 percent change
Parkinson's Disease
Primary: Change From Baseline to Week 26 in UPDRS Total Score — -0.18; -3.18 units on a scale — p=0.0254